Legal developments affecting the healthcare industry.
Originally published in Healthcare News and Healthcare Michigan. Reprinted with Permission LOI drift is one of the more underappreciated risks in healthcare transactions, and one of the more avoidable ones. It happens when the terms agreed to in a letter of intent, such as a co-branding commitment or a governance right, simply don’t make it into the definitive …
Continue reading “From Intent to Agreement: Closing the Gap on LOI Drift in Healthcare Deals”
Originally published in the April 2026 edition of Healthcare News. As artificial intelligence (AI)‑driven tools proliferate across clinical care, diagnostics, and health insurance operations, the U.S. regulatory landscape is shifting rapidly in 2026. Absent a comprehensive federal AI statute, healthcare organizations face a patchwork of federal oversight (primarily through the FDA, CMS, and HHS) layered …
Continue reading “The State of AI Regulation in Healthcare: Still Complicated”
Previously published in Healthcare News and Healthcare Michigan On Jan. 29, 2026, President Trump signed an executive order with the potential to significantly impact behavioral health and substance use disorder providers. Executive Order 14379, titled “The Great American Recovery Initiative,” outlines the Trump Administration’s efforts to coordinate the federal government’s response to substance use disorders and the addiction …
Continue reading “The Great American Recovery Initiative: What SUD Providers Need To Know”
2025 was a busy year for federal health law, with several major laws, regulations, and policy changes. Many of these will still be relevant in 2026. The following is a brief overview of the most significant developments and what they may mean going forward. The “One Big Beautiful Bill Act” (OBBBA) The OBBBA was a …
Continue reading “6 Key Federal Health Law Changes in 2025 and Their 2026 Impact”